Navigation Links
Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
Date:4/20/2012

KISSIMMEE, Fla., April 20, 2012 /PRNewswire/ -- Miramar Labs announced today 18 months of follow-up data to a study which assessed the efficacy and safety of the miraDry System, a non-invasive technology that was cleared by the U.S. Food & Drug Administration (FDA) to treat primary axillary hyperhidrosis (excessive underarm sweat). The data showed patients treated with the miraDry System experienced, on average, 82 percent sweat reduction at 18-months post procedure, consistent with the results seen at the 12 months check-in date. The study also demonstrated patient satisfaction and efficacy of more than 90 percent. The data was presented today at the American Society of Laser Medicine & Surgery Annual Conference in Kissimmee, Fla. A more detailed description of the study's 12-month results will be published in the May issue of Dermatologic Surgery.

"The recent data is exciting because it shows that the improvements made to the miraDry System and protocol over the earlier FDA approval study have increased patient satisfaction and efficacy while maintaining an excellent safety record," said Dr. Mark Lupin, director and founder of Cosmedica in Victoria, B.C. and co-author of the Dermatologic Surgery journal article. "Additionally, histology shows that the device's mechanism of action does in fact destroy sweat cells; once destroyed, sweat glands do not regenerate. The miraDry Procedure provides a lasting option for sweat sufferers enduring an often embarrassing condition."

In the U.S., 1 in 5 adults suffer from bothersome underarm sweat. The miraDry Procedure delivers energy non-invasively to the underarm area where the sweat glands reside, creating localized heat to eliminate the glands.

Thirty-one adults with excessive underarm sweat were enrolled in the study at two centers in Canada. The study participants had follow-up office visits for 12 months after all procedur
'/>"/>

SOURCE Miramar Labs
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. New Study Shows Masimos Noninvasive Pleth Variability Index Provides Similar Ability to Assess Fluid Responsiveness During Surgery as More Costly and Invasive Method
3. Phase 2b Study of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Shows Undetectable Virus in HCV Genotype-1 Patients 12 Weeks After Treatment Ended (SVR12)
4. CrystalGenomics Announces Positive Results from Phase 2b Osteoarthritis Study of CG100649
5. Morphotek®, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer
6. Biodel Reports Positive Top-Line Results from Study of Experimental Ultra-Rapid-Acting Insulin Formulations
7. Encouraging Phase III Study Results Show PET Imaging with Florbetaben Reliably Detects Beta-Amyloid in the Brain
8. Legacy® and Lung Cancer Alliance Hail the Release of New Study Showing Lung Cancer Screening is Cost Effective
9. Bioness Initiates Study of Neuromodulation System for Chronic Peripheral Nerve Pain
10. Study Confirms Soy Isoflavones Reduce Menopausal Hot Flashes
11. Bionovos Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 ResMed Inc. (NYSE: RMD ) today ... year ended June 30, 2015 results on Thursday, July 30, ... press release with ResMed,s results will be issued after 1:00 ... webcast to discuss operating results and future outlook. ... US Pacific Time and the live webcast of the call ...
(Date:7/2/2015)... N.Y. , July 2, 2015  Before you head ... ahead so you can stay safe and healthy. Take steps ... #summersafety. Infographic http://nyackhospital.org/summersafety Protect Your Skin ... from the sun can increase your risk of skin cancer. ... shade as much as possible, especially during midday hours. Wear ...
(Date:7/2/2015)... DALLAS , July 2, 2015 ... Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial ... Trends & Global Forecast to 2020", published by MarketsandMarkets, the ... and is projected to reach $6.20 Billion by 2020, at ... Browse 8 4 market ...
Breaking Medicine Technology:ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4
... Calif., Oct. 19 Xytis Inc., a privately ... treat,central nervous system (CNS) diseases, today announced that ... Financial Officer. Mr. Busenbark,has more than 25 years ... industries. During a 23 year career at Baxter,Healthcare, ...
... to Kick-Off Faces of Influenza Campaign in New York City Monday, ... ... Actress Jennifer Garner joins the,American Lung Association in a new role as ... the many,"faces" of influenza, she will encourage families to speak with their,health-care ...
Cached Medicine Technology:Xytis Names Gordon H. Busenbark as Chief Financial Officer 2Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination 2Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination 3Actress and Mother Jennifer Garner Joins American Lung Association to Encourage Americans to Get an Influenza Vaccination 4
(Date:7/2/2015)... ... July 02, 2015 , ... Get ready to ... PERFORMANCE SOCKS. Since the socks were first introduced, they have rapidly been gaining ... has inspired four new, fun shades including: blue, lime, pink and red. ...
(Date:7/2/2015)... ... July 02, 2015 , ... Six months ahead of his ... walk to raise awareness and money for the Pulmonary Hypertension Association (PHA). Stevenson ... PHA’s headquarters near Washington, D.C. by mid-September. He left Glasgow, Mont. yesterday morning and ...
(Date:7/2/2015)... Diego, CA (PRWEB) , ... July 02, 2015 , ... ... and a passion for social fitness. Built to function as a lifestyle community, Active ... giving them the opportunity to network, meet, and participate in discussions or group events. ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... - pipeline review 2015” provides comprehensive information on the pipeline products with ... on negative pressure wound therapy (NPWT) with 22 market data tables and ...
(Date:7/2/2015)... ... July 02, 2015 , ... CleanItSupply.com, ... it has reached an agreement to acquire eRubbermaid.com, an Internet retailer of ... Rubbermaid Commercial Products on the web today. , “eRubbermaid.com’s search ...
Breaking Medicine News(10 mins):Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:CleanItSupply.com Acquires eRubbermaid.com 2
... Jenifer Goodwin HealthDay Reporter , SUNDAY, Feb. 26 ... from adult human ovaries that can mature into eggs that ... upend longstanding scientific theory, could potentially lead to new ... fertility. It was long believed that women were born ...
... MONDAY, Feb. 27 (HealthDay News) -- A potentially dangerous heart ... mental and physical decline in older people at risk for ... Feb. 27 in the Canadian Medical Association Journal , ... people in 40 countries, aged 55 and older. All of ...
... improves lives and may save money. There are two very ... but it is unclear which is the most effective and ... The BY-BAND study led by the University of Bristol and ... Assessment (NIHR HTA) programme will compare the outcomes of stomach ...
... for type 2 diabetes, improves blood sugar control and is ... of creating a dangerous drop in blood sugar, called hypoglycemia, ... phase 2 randomized trial were published Online First Sunday in ... most common form of diabetes accounting for 90 percent of ...
... -- An experimental drug improves patients, blood sugar control ... patients with type 2 diabetes, according to the results of ... the more prevalent form of the disease, accounting for about ... 2 diabetes involves a gradual decline in how insulin responds ...
... Breast-feeding exclusively is recommended for a baby,s first six months ... a baby is at least 12 months old, the American ... After 12 months, breast-feeding can continue as long as both ... statement published online Feb. 27 and in the March print ...
Cached Medicine News:Health News:Stem Cell Finding Could Expand Women's Lifetime Supply of Eggs 2Health News:Stem Cell Finding Could Expand Women's Lifetime Supply of Eggs 3Health News:Irregular Heartbeat May Predict Mental Decline in Some 2Health News:Which type of obesity surgery is best? 2Health News:Diabetes drug gets patients with Type 2 diabetes on target 2Health News:Experimental Drug Shows Promise Against Type 2 Diabetes 2Health News:Experimental Drug Shows Promise Against Type 2 Diabetes 3
... automated, random access immunoassay ... assays available worldwide. thyroid, ... therapeutic drug, serology, anemia ... be performed on a ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
The Embla 96/384 well washer is a top-loading, robotic-compatible plate washer for 96- and 384-well microplate washing. It is ideal for ELISAs and most cell applications....
Elisa Plate Reader...
Medicine Products: